Camber Capital Management’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,500,000
Closed -$76.4M 30
2025
Q1
$76.4M Sell
1,500,000
-1,700,000
-53% -$86.6M 2.72% 6
2024
Q4
$144M Sell
3,200,000
-300,000
-9% -$13.5M 3.34% 5
2024
Q3
$130M Hold
3,500,000
4.12% 6
2024
Q2
$107M Sell
3,500,000
-500,000
-13% -$15.3M 2.96% 10
2024
Q1
$116M Hold
4,000,000
2.85% 11
2023
Q4
$110M Buy
4,000,000
+600,000
+18% +$16.5M 2.81% 10
2023
Q3
$76.2M Buy
3,400,000
+900,000
+36% +$20.2M 2.51% 16
2023
Q2
$102M Hold
2,500,000
3.31% 12
2023
Q1
$121M Sell
2,500,000
-250,000
-9% -$12.1M 3.72% 11
2022
Q4
$105M Buy
2,750,000
+300,000
+12% +$11.5M 3.6% 10
2022
Q3
$123M Hold
2,450,000
3.77% 8
2022
Q2
$98.1M Buy
2,450,000
+700,000
+40% +$28M 4.26% 9
2022
Q1
$65.3M Buy
1,750,000
+1,000,000
+133% +$37.3M 2.36% 17
2021
Q4
$29.9M Hold
750,000
1.03% 25
2021
Q3
$27.9M Buy
+750,000
New +$27.9M 0.86% 26
2017
Q3
Sell
-500,000
Closed -$9.17M 24
2017
Q2
$9.17M Sell
500,000
-750,000
-60% -$13.7M 0.45% 27
2017
Q1
$12.3M Buy
+1,250,000
New +$12.3M 0.5% 25
2016
Q4
Sell
-2,000,000
Closed -$28M 38
2016
Q3
$28M Buy
2,000,000
+500,000
+33% +$7.01M 1.23% 21
2016
Q2
$10.5M Buy
1,500,000
+606,100
+68% +$4.25M 0.51% 33
2016
Q1
$5.76M Buy
893,900
+393,900
+79% +$2.54M 0.34% 38
2015
Q4
$16.2M Buy
+500,000
New +$16.2M 1.05% 24
2015
Q1
Sell
-525,000
Closed -$27.2M 40
2014
Q4
$27.2M Buy
525,000
+366,851
+232% +$19M 1.81% 21
2014
Q3
$6.96M Buy
+158,149
New +$6.96M 0.65% 29